Antithrombotic Therapy in Patients With Thrombocytopenic Cancer: Outcomes Associated With Reduced-Dose, Low-Molecular-Weight Heparin During Hospitalization

Conclusion:
In hospitalized patients having thrombocytopenia with CAT, reduced-dose low-molecular-weight heparin was generally efficacious.

Source: Clinical and Applied Thrombosis/Hemostasis - October 9, 2014 Category: Hematology Authors: Babilonia, K. M., Golightly, L. K., Gutman, J. A., Hassell, K. L., Kaiser, J. N., Kiser, T. H., Klem, P. M., Trujillo, T. C. Tags: Original Articles Source Type: research